Amicus Therapeutics Congratulates Executive Chairman John F. Crowley on Appointment as Next President and CEO of BIO
Crowley to Step Down from Amicus Board of Directors in March 2024 and Become Amicus Chairman Emeritus
Michael Raab, Current Lead Independent Director, to Become Chairman of Amicus Board of Directors
Related news for (FOLD)
- Amicus Therapeutics Announces First Quarter 2025 Financial Results and Corporate Updates
- Dimerix and Amicus Therapeutics Announce Exclusive License Agreement for DMX-200 in the United States
- Amicus Therapeutics Announces Full-Year 2024 Financial Results and Corporate Updates
- Amicus Therapeutics Reports Preliminary 2024 Revenue and Provides 2025 Strategic Outlook
- 24/7 Market News Snapshot 17 October, 2024 – Amicus Therapeutics, Inc (NASDAQ:FOLD)